KR20040054803A - 카테터 조성물 및 그의 용도 - Google Patents

카테터 조성물 및 그의 용도 Download PDF

Info

Publication number
KR20040054803A
KR20040054803A KR10-2004-7007931A KR20047007931A KR20040054803A KR 20040054803 A KR20040054803 A KR 20040054803A KR 20047007931 A KR20047007931 A KR 20047007931A KR 20040054803 A KR20040054803 A KR 20040054803A
Authority
KR
South Korea
Prior art keywords
catheter
plasminogen activator
composition
package
sample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
KR10-2004-7007931A
Other languages
English (en)
Korean (ko)
Inventor
찰스 피. 셈바
Original Assignee
제넨테크, 인크.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 제넨테크, 인크. filed Critical 제넨테크, 인크.
Publication of KR20040054803A publication Critical patent/KR20040054803A/ko
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Surgery (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Detergent Compositions (AREA)
KR10-2004-7007931A 2001-11-26 2002-11-25 카테터 조성물 및 그의 용도 Abandoned KR20040054803A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US33336901P 2001-11-26 2001-11-26
US60/333,369 2001-11-26
PCT/US2002/037878 WO2003045466A2 (en) 2001-11-26 2002-11-25 Catheter composition and uses thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
KR1020107019474A Division KR20100102745A (ko) 2001-11-26 2002-11-25 카테터 조성물 및 그의 용도

Publications (1)

Publication Number Publication Date
KR20040054803A true KR20040054803A (ko) 2004-06-25

Family

ID=23302492

Family Applications (2)

Application Number Title Priority Date Filing Date
KR1020107019474A Ceased KR20100102745A (ko) 2001-11-26 2002-11-25 카테터 조성물 및 그의 용도
KR10-2004-7007931A Abandoned KR20040054803A (ko) 2001-11-26 2002-11-25 카테터 조성물 및 그의 용도

Family Applications Before (1)

Application Number Title Priority Date Filing Date
KR1020107019474A Ceased KR20100102745A (ko) 2001-11-26 2002-11-25 카테터 조성물 및 그의 용도

Country Status (28)

Country Link
US (3) US20030206906A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP1455858A4 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JP4458240B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (2) KR20100102745A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CN (1) CN100478027C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AR (1) AR037437A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (2) AU2002365408B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BR (1) BR0215098A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA2467645C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CO (1) CO5580795A2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EA (1) EA007594B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EC (2) ECSP045123A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HR (1) HRP20040502A2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HU (1) HUP0600436A3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (2) IL162083A0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IS (1) IS7275A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ME (1) ME00015B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MX (1) MXPA04004948A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MY (1) MY140404A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NO (1) NO331700B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NZ (1) NZ533029A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PL (1) PL371760A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
RS (1) RS46204A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
TW (1) TWI262794B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
UA (1) UA81235C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
UY (1) UY27550A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
WO (1) WO2003045466A2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA200404024B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA04004948A (es) * 2001-11-26 2004-08-11 Genentech Inc Composicion de cateter y sus usos.
US7128923B2 (en) * 2003-03-31 2006-10-31 Procyte Corporation Preserved and stable compositions containing peptide copper complexes and method related thereto
CA2662083C (en) * 2006-08-28 2016-09-20 Omnio Healer Ab Novel drug target of preventing and treating periodontal disease, improving healing of periodontal wounds and promoting oral health
CA2662101C (en) * 2006-08-28 2015-07-07 Omnio Healer Ab Candidates against infection
JP5871449B2 (ja) * 2006-11-07 2016-03-01 ジェネンテック， インコーポレイテッド 組織プラスミノゲン活性化因子バリアントの使用
RU2323001C1 (ru) * 2007-05-30 2008-04-27 Общество с ограниченной ответственностью "Научно-производственное предприятие "Техноген" Фармацевтическая композиция, обладающая фибринолитическим действием
WO2008150375A1 (en) 2007-06-01 2008-12-11 Arrow International, Inc. Combined fibrinolytic and antimicrobial catheter and uses thereof
CN103181893A (zh) * 2007-09-07 2013-07-03 联合治疗公司 针对革兰氏阴性细菌具有选择性杀菌活性的缓冲液及其使用方法
US8545459B2 (en) * 2009-02-25 2013-10-01 Teleflex Medical Incorporated Stabilized enzyme compositions
US9333280B2 (en) 2009-02-25 2016-05-10 Teleflex Medical Incorporated Stabilized enzyme compositions
EP2464406B1 (en) * 2009-08-10 2016-10-26 Proviflo, LLC Catheter lock solutions utilizing tocopherol and mid-chain fatty acids
CN103083726A (zh) * 2013-03-04 2013-05-08 昆明市第一人民医院 一种肝脏组织脱细胞液
WO2016201269A2 (en) 2015-06-11 2016-12-15 Proviflo, Llc Graft-port hemodialysis systems, devices and methods

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI831484A7 (fi) * 1982-05-05 1983-11-06 Genentech Inc Ihmiskudoksen plasminogeenien aktivaattori.
US5000185A (en) * 1986-02-28 1991-03-19 Cardiovascular Imaging Systems, Inc. Method for intravascular two-dimensional ultrasonography and recanalization
US5019096A (en) * 1988-02-11 1991-05-28 Trustees Of Columbia University In The City Of New York Infection-resistant compositions, medical devices and surfaces and methods for preparing and using same
US5270198A (en) * 1988-05-20 1993-12-14 Genentech, Inc. DNA molecules encoding variants of tissue plasminogen activators, vectors, and host cells
GB8820945D0 (en) * 1988-09-07 1988-10-05 Smith & Nephew Medical articles
FR2661790B1 (fr) * 1990-05-03 1995-08-25 France Etat Dispositif d'amplification tres large bande continu-hyperfrequences, notamment realisable en circuit integre.
AU7998091A (en) * 1990-05-17 1991-12-10 Harbor Medical Devices, Inc. Medical device polymer
US5399158A (en) * 1990-05-31 1995-03-21 The United States Of America As Represented By The Secretary Of The Army Method of lysing thrombi
US5363754A (en) * 1991-09-03 1994-11-15 Grainco Queensland Co-Operative Association Limited Apparatus for preparing animal feedstuff from cotton seed
JPH05291891A (ja) * 1992-02-14 1993-11-05 Ricoh Co Ltd 一次乱数パルス列発生回路装置
ATE246000T1 (de) * 1992-06-03 2003-08-15 Genentech Inc Varianten des gewebeplasminogenaktivators mit verbesserter therapeutischer wirkung
US5688516A (en) * 1992-11-12 1997-11-18 Board Of Regents, The University Of Texas System Non-glycopeptide antimicrobial agents in combination with an anticoagulant, an antithrombotic or a chelating agent, and their uses in, for example, the preparation of medical devices
US5362754A (en) * 1992-11-12 1994-11-08 Univ. Of Tx Md Anderson Cancer Center M-EDTA pharmaceutical preparations and uses thereof
NZ276633A (en) 1993-11-24 1998-04-27 Du Pont Merck Pharma Isoxazole and isoxazoline derivatives and pharmaceutical compositions thereof
US5849736A (en) * 1993-11-24 1998-12-15 The Dupont Merck Pharmaceutical Company Isoxazoline and isoxazole fibrinogen receptor antagonists
US5885967A (en) * 1994-03-04 1999-03-23 Eli Lilly And Company Antithrombotic agents
US5509896A (en) * 1994-09-09 1996-04-23 Coraje, Inc. Enhancement of thrombolysis with external ultrasound
US5772640A (en) * 1996-01-05 1998-06-30 The Trustees Of Columbia University Of The City Of New York Triclosan-containing medical devices
CA2178541C (en) * 1995-06-07 2009-11-24 Neal E. Fearnot Implantable medical device
US5932299A (en) * 1996-04-23 1999-08-03 Katoot; Mohammad W. Method for modifying the surface of an object
US5840733A (en) * 1996-07-01 1998-11-24 Redcell, Canada, Inc. Methods and compositions for producing novel conjugates of thrombin inhibitors and endogenous carriers resulting in anti-thrombins with extended lifetimes
US5837688A (en) * 1996-11-27 1998-11-17 Gelfand; Mathew I. Use of thrombolytic reagents for prevention of vascular disease
GB9626795D0 (en) * 1996-12-23 1997-02-12 Geistlich Soehne Ag Combating infection in delivery systems
AU5526098A (en) 1996-12-23 1998-07-17 Biochem Pharma Inc. Bicyclic thrombin inhibitors
US5981826A (en) * 1997-05-05 1999-11-09 Georgia Tech Research Corporation Poly(vinyl alcohol) cryogel
JPH10328293A (ja) 1997-06-04 1998-12-15 Unitika Ltd 医療用具及びその製造方法
US6206914B1 (en) * 1998-04-30 2001-03-27 Medtronic, Inc. Implantable system with drug-eluting cells for on-demand local drug delivery
US6166007A (en) * 1998-07-02 2000-12-26 Sodemann; Klaus Antimicrobial locks comprising taurinamide derivatives and carboxylic acids and/or salts thereof
US6174537B1 (en) * 1998-09-25 2001-01-16 Becton, Dickinson And Company Catheter flush solution and method for its use
AR022909A1 (es) * 1999-03-11 2002-09-04 Du Pont Pharm Co Sinergia entre heparina de bajo peso molecular e inhibidores de la agregacion plaquetaria, que provee una terapia combinada para la prevencion ytratamiento de diversas afecciones tromboembolicas
IL144798A0 (en) 1999-03-11 2002-06-30 Du Pont Pharm Co Treatment of thrombosis by combined use of a factor xa inhibitor and aspirin, tissue plasminogen activator (tpa), a gpiib/iiia antagonist, low molecular weight heparin or heparin
CA2302720C (en) 1999-03-29 2009-07-14 Ed Geistlich Sohne Ag Fur Chemische Industrie Anticoagulant/sterilizing compositions and methods
US6187768B1 (en) * 1999-06-01 2001-02-13 Becton, Dickinson And Company Kit for flushing medical devices and method of preparation
EP1060747A3 (en) * 1999-06-16 2001-12-05 New York Blood Center, Inc. Fibrin(ogen) degradation and clot lysis by fibrinolytic metalloproteinase
US6592564B2 (en) * 1999-07-23 2003-07-15 Vasca, Inc. Methods and kits for locking and disinfecting implanted catheters
US6350251B1 (en) * 2000-01-18 2002-02-26 Biolink Corporation Biocidal locks
US20010031981A1 (en) * 2000-03-31 2001-10-18 Evans Michael A. Method and device for locating guidewire and treating chronic total occlusions
JP2005517460A (ja) 2000-05-10 2005-06-16 アッシュ・アクセス・テクノロジー・インコーポレーテッド 光酸化剤を含むカテーテルロック溶液
US6772640B1 (en) * 2000-10-10 2004-08-10 Mks Instruments, Inc. Multi-temperature heater for use with pressure transducers
US20050215978A1 (en) * 2001-05-25 2005-09-29 Ash Stephen R Method of enhancing catheter patency using a citrate salt catheter lock solution
MXPA04004948A (es) * 2001-11-26 2004-08-11 Genentech Inc Composicion de cateter y sus usos.
US20070014779A1 (en) * 2002-11-14 2007-01-18 Genentech, Inc. Plasminogen activator variant formulations
ATE354380T1 (de) 2003-02-03 2007-03-15 Polaschegg Hans-Dietrich Dr Te Zusammensetzung zur prävention von infektionen durch subkutane prothesen
US7696182B2 (en) 2004-11-02 2010-04-13 Nd Partners, Llc Antimicrobial locking solutions comprising taurinamide derivatives and biologically acceptable salts and acids, with the addition of small concentrations of heparin
US7749529B2 (en) 2005-02-08 2010-07-06 Ash Access Technology, Inc. Catheter lock solution comprising citrate and a paraben
JP5871449B2 (ja) 2006-11-07 2016-03-01 ジェネンテック， インコーポレイテッド 組織プラスミノゲン活性化因子バリアントの使用

Also Published As

Publication number Publication date
HUP0600436A2 (en) 2006-09-28
JP2005510302A (ja) 2005-04-21
CN1617738A (zh) 2005-05-18
NZ533029A (en) 2006-05-26
ME00015B (me) 2010-06-10
US7829082B2 (en) 2010-11-09
MEP8008A (xx) 2010-02-10
TWI262794B (en) 2006-10-01
EA007594B1 (ru) 2006-12-29
WO2003045466A2 (en) 2003-06-05
WO2003045466A3 (en) 2003-10-09
TW200303743A (en) 2003-09-16
EP1455858A4 (en) 2006-02-15
CA2467645C (en) 2017-01-17
ECSDI045123S (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 2004-07-23
RS46204A (en) 2006-10-27
CN100478027C (zh) 2009-04-15
US20060257390A1 (en) 2006-11-16
BR0215098A (pt) 2004-12-14
AU2002365408B2 (en) 2008-04-24
KR20100102745A (ko) 2010-09-24
AU2008203131A1 (en) 2008-08-07
IS7275A (is) 2004-05-21
NO331700B1 (no) 2012-02-27
CA2467645A1 (en) 2003-06-05
ZA200404024B (en) 2005-07-27
NO20042693L (no) 2004-08-25
AR037437A1 (es) 2004-11-10
US20060246050A1 (en) 2006-11-02
EP1455858A2 (en) 2004-09-15
UA81235C2 (en) 2007-12-25
HRP20040502A2 (en) 2004-12-31
EA200400712A1 (ru) 2005-06-30
IL162083A (en) 2012-12-31
IL162083A0 (en) 2005-11-20
MY140404A (en) 2009-12-31
CO5580795A2 (es) 2005-11-30
JP4458240B2 (ja) 2010-04-28
AU2002365408A1 (en) 2003-06-10
US20030206906A1 (en) 2003-11-06
PL371760A1 (en) 2005-06-27
MXPA04004948A (es) 2004-08-11
HUP0600436A3 (en) 2010-12-28
ECSP045123A (es) 2004-07-23
UY27550A1 (es) 2003-06-30

Similar Documents

Publication Publication Date Title
US7829082B2 (en) Catheter composition and uses thereof
US10350334B2 (en) Catheter locking solution having antimicrobial and anticoagulation properties
US6187768B1 (en) Kit for flushing medical devices and method of preparation
RU2734929C2 (ru) Раствор замка катетера и терапия с применением замка катетера
Fraenkel et al. Can we achieve consensus on central venous catheter-related infections?
US20150237854A1 (en) Transdermal venous access locking solutions
Houlihan et al. Pharmacodynamics of vancomycin alone and in combination with gentamicin at various dosing intervals against methicillin-resistant Staphylococcus aureus-infected fibrin-platelet clots in an in vitro infection model
Bergeron et al. Continuous vs. intermittent administration of antimicrobial agents: tissue penetration and efficacy in vivo
Bergeron et al. Influence of constant infusion versus bolus injections of antibiotics on in vivo synergy
JP2014525436A (ja) 経皮的静脈アクセスロック溶液
Lentz et al. In vitro stability and compatibility of tenecteplase in central venous access devices
Weck et al. Alteplase as a catheter locking solution: in vitro evaluation of biochemical stability and antimicrobial properties
RU2783927C2 (ru) Раствор замка катетера и терапия с применением замка катетера
HK1259863A1 (en) Catheter locking solution and catheter locking therapy
福島修司 et al. Pharmacokinetic studies of cefoperazone after bolus injection in patients with benign prostatic hypertrophy.
FUKUSHIMA et al. PHARMACOKINETIC STUDIES OF CEFOPERAZONE AFTER BOLUS INJECTION IN PATIENTS WITH BENIGN PROSTATIC HYPERTROPHY

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20040525

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
AMND Amendment
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20071123

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20091016

Patent event code: PE09021S01D

AMND Amendment
E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20100318

Patent event code: PE09021S01D

AMND Amendment
E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20100701

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20100318

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I

Patent event date: 20091016

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I

J201 Request for trial against refusal decision
PJ0201 Trial against decision of rejection

Patent event date: 20100802

Comment text: Request for Trial against Decision on Refusal

Patent event code: PJ02012R01D

Patent event date: 20100701

Comment text: Decision to Refuse Application

Patent event code: PJ02011S01I

Appeal kind category: Appeal against decision to decline refusal

Decision date: 20120316

Appeal identifier: 2010101005890

Request date: 20100802

A107 Divisional application of patent
AMND Amendment
PA0104 Divisional application for international application

Comment text: Divisional Application for International Patent

Patent event code: PA01041R01D

Patent event date: 20100901

PB0901 Examination by re-examination before a trial

Comment text: Amendment to Specification, etc.

Patent event date: 20100901

Patent event code: PB09011R02I

Comment text: Request for Trial against Decision on Refusal

Patent event date: 20100802

Patent event code: PB09011R01I

Comment text: Amendment to Specification, etc.

Patent event date: 20100518

Patent event code: PB09011R02I

Comment text: Amendment to Specification, etc.

Patent event date: 20091216

Patent event code: PB09011R02I

Comment text: Amendment to Specification, etc.

Patent event date: 20071123

Patent event code: PB09011R02I

B601 Maintenance of original decision after re-examination before a trial
PB0601 Maintenance of original decision after re-examination before a trial

Comment text: Report of Result of Re-examination before a Trial

Patent event code: PB06011S01D

Patent event date: 20101001

PJ1301 Trial decision

Patent event code: PJ13011S01D

Patent event date: 20120316

Comment text: Trial Decision on Objection to Decision on Refusal

Appeal kind category: Appeal against decision to decline refusal

Request date: 20100802

Decision date: 20120316

Appeal identifier: 2010101005890

PS0901 Examination by remand of revocation
S901 Examination by remand of revocation
E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20120420

Patent event code: PE09021S01D

GRNO Decision to grant (after opposition)
PS0701 Decision of registration after remand of revocation

Patent event date: 20121031

Patent event code: PS07012S01D

Comment text: Decision to Grant Registration

Patent event date: 20120316

Patent event code: PS07011S01I

Comment text: Notice of Trial Decision (Remand of Revocation)

NORF Unpaid initial registration fee
PC1904 Unpaid initial registration fee